ZUPREVO Solution

Страна: Канада

Език: френски

Източник: Health Canada

Активна съставка:

Tildipirosine

Предлага се от:

INTERVET CANADA CORP

дозиране:

180MG

Лекарствена форма:

Solution

Композиция:

Tildipirosine 180MG

Начин на приложение:

Sous-cutanée

Броя в опаковка:

20/50/100/250ML

Вид предписание :

Prescription

Терапевтична група:

Bétails

Каталог на резюме:

Numéro de groupe d'ingrédients actifs (GIA) :0153184001

Статус Оторизация:

APPROUVÉ

Дата Оторизация:

2013-12-12

Листовка

PACKAGE INSERT - ENGLISH
Version 15MAR2017
Page 1 of 21
DIN 02387719
ZUPREVO
®
TILDIPIROSIN INJECTION, 180 MG/ML
VETERINARY USE ONLY
ANTIBIOTIC
For Subcutaneous Use in Beef and Non-lactating Dairy Cattle Only.
DESCRIPTION: ZUPREVO is a clear yellowish ready-to-use sterile
injectable solution
containing tildipirosin, a semi-synthetic macrolide antibiotic. Each
mL of ZUPREVO
contains: ACTIVE INGREDIENT: 180.0 mg of tildipirosin as the free
base; NON-
MEDICINAL INGREDIENTS: citric acid monohydrate, propylene glycol, and
water qs.
INDICATIONS: ZUPREVO is indicated for the treatment of bovine
respiratory disease
(BRD) associated with _Mannheimia haemolytica, Pasteurella multocida_
and _Histophilus _
_somni_. ZUPREVO is also indicated for the reduction of morbidity
associated with BRD in
feedlot
calves,
caused
by
_Mannheimia _
_haemolytica, _
_Pasteurella _
_multocida _
and
_Histophilus somni_, during the first 14 days in the feedlot, when
administered at the time
of arrival.
DOSAGE AND ADMINISTRATION: ZUPREVO should be administered in the neck
of
cattle by a single subcutaneous injection at a dose rate of 4 mg/kg
body weight (1 mL/45
kg). Do not inject more than 10 mL into a single site. Do not puncture
the stopper more
than 20 times. Most animals will respond to treatment within 3 to 5
days. If no
improvement is observed, the diagnosis should be re-evaluated.
Note: To limit the development of antimicrobial resistance, ZUPREVO
should only be
used as an arrival treatment in feedlot calves when BRD has been
diagnosed and
calves are at high risk of developing BRD. Calves at high risk of
developing BRD
typically experience one or more of the following risk factors:
commingling from multiple
sales barns/sources; extended transport times and shrink; exposure to
wet or cold
weather conditions or wide temperature swings; stressful arrival
processing procedures
(such as castration, dehorning, or branding); and, recent weaning and
poor vaccination
history.
CONTRA-INDICATIONS: ZUPREVO is contraindicated in animals previously
fo